Clinical Management of Menstruation in Adolescent Females with Developmental Delay

Endocrinologist

Volumn 14, Issue 2, 2004, Pages 87-92

  Backeljauw, Philippe F ^a   Rose, Susan R ^a   Lawson, Margaret ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Contraception; Developmental delay; Menstruation control

Indexed keywords

CALCIUM; CYCLESSA; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; LEVONORGESTREL; LOESTRIN FE; MEDROXYPROGESTERONE ACETATE; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D;

ADOLESCENT; BEHAVIOR DISORDER; BONE MINERALIZATION; CHILD HEALTH; CLINICAL PRACTICE; CONTRACEPTION; DEVELOPMENTAL DISORDER; DRUG COST; DRUG FORMULATION; ESTROGEN DEFICIENCY; FATIGUE; FEMALE; HUMAN; INJECTION PAIN; MEDICAL SPECIALIST; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; MOOD DISORDER; OSTEOPENIA; PERSONAL HYGIENE; POPULATION; PRACTICE GUIDELINE; QUESTIONNAIRE; REVIEW; SEXUALITY; SIDE EFFECT; THROMBOEMBOLISM; WEIGHT GAIN;

EID: 1842483908     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000123566.01901.e7     Document Type: Review

References (26)

1. Chamberlain A, Rauh J, Passer A, et al. Issues in fertility control for mentally retarded female adolescents: I. Sexual activity, sexual abuse, and contraception. Pediatrics. 1984;73:445-450.
2. Caparulo F, Kempton W. Sexual health needs of the mentally retarded adolescent female. Issues Health Care Women. 1981;3:35-46.
3. Elkins TE, Haefner HK. Sexually related healthcare for developmentally disabled adolescents. Adolesc Med. 1992;3:331-339.
4. Elkins TE, Gafford LS, Wilks CS, et al. A model clinic approach to the reproductive health concerns of the mentally handicapped. Obstet Gynecol. 1986;68:185-188.
5. Richman GS, Reiss ML, Bauman KE, et al. Teaching menstrual care to mentally retarded women: acquisition, generalization, and maintenance. J Appl Behav Anal. 1984;17:441-451.
6. Kreutner KA. Sexuality, fertility, and the problems of menstruation in mentally retarded adolescents. Pediatr Clin North Am. 1981;28:475-480.
7. Hammar SL, Wright LS, Jensen DL. Sex education for the retarded adolescent: a survey of parental attitudes and methods of management in fifty adolescent retardates. Clin Pediatr (Phila). 1967;6:621-627.
8. Wingfield M, Healy DL, Nicholson A. Gynaecological care for women with intellectual disability. Med J Aust. 1994;160:536-538.
9. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand. 1976;54:321-347.
10. Dana-Haeri J, Rickens A. Effect of norethisterone on seizures associated with menstruation. Epilepsia. 1983;24:377-381.
11. Quint EH, Elkins TE, Sorg CA, et al. The treatment of cyclical behavioral changes in women with mental disabilities. J Pediatr Adolesc Gynecol. 1999;12:139-142.
12. Rubinow DR, Roy-Byrne P. Premenstrual syndrome: overview from a methodologic perspective. Am J Psychiatry. 1984;141:163-172.
13. Grover SR. Menstrual and contraceptive management in women with an intellectual disability. Med J Aust. 2002;176:108-110.
14. Siddiqi SU, Van Dyke DC, Donohoue P. Premature sexual development in individuals with neurodevelopmental disabilities. Dev Med Child Neurol. 1999;41:392-395.
15. Henderson RC, Lark RK, Gurka MJ, et al. Bone mineral density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002;110(1 part 1):e5.
16. Farhat G, Yamout B, Mikati MA, et al. Effects of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;14:1348-1353.
17. Beckman CRB, Gittler M, Barzansky BM, et al. Gynecologic healthcare of women with disabilities. Obstet Gynecol. 1989;74:75-79.
18. Haefner HK, Elkins TE. Contraceptive management for female adolescents with mental retardation and handicapping abilities. Curr Opin Obstet Gynecol. 1991;3:820-824.
19. Servais L, Jacques D, Leach R, et al. Contraception of women with intellectual disability: prevalence and determinants. J Intellect Disabil Res. 2002;46:108-119.
20. Diekema DS. Involuntary sterilization of persons with mental retardation: an ethical analysis. Ment Retard Dev Disabil Res Rev. 2003;9:21-26.
21. American Academy of Pediatrics Committee on Bioethics. Sterilization of minors with developmental disabilities. Pediatrics. 1999;104:337-340.
22. Elkins TE, Hoyle D, Darnton T, et al. The use of a societally based ethics/advisory committee to aid in decisions to sterilize mentally handicapped patients. Adolesc Pediatr Gynecol. 1988;1:190-194.
23. Rauh JL, Dine MS, Biro FM, et al. Sterilization for the mentally retarded adolescent. Balancing the equities/the Cincinnati experience. J Adolesc Health Care. 1989;10:467-472.
24. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68:89-96.
25. Kaunitz AM, Garceau RJ, Cromie MA. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection and Ortho-Novum 7/7/7 oral contraceptive. Contraception. 1999;60:189-200.
26. Bauer J. Interactions between hormones and epilepsy in female patients. Epilepsia. 2001;42(suppl 3):20-22.